TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus
Open Access
- 23 August 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 94 (1) , 60-66
- https://doi.org/10.1002/ijc.1438
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's LymphomaThe Journal of Experimental Medicine, 2000
- Oncogene Expression in Tumour Cells of Pediatric Hodgkin's Disease in Argentina — Correlation with Epstein Barr Virus PresencePathology - Research and Practice, 1998
- THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASEAnnual Review of Immunology, 1998
- Epstein--Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assaysJournal of General Virology, 1995
- PCR-mismatch analysis of p53 gene mutation in Hodgkin's diseaseThe Journal of Pathology, 1995
- EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.Proceedings of the National Academy of Sciences, 1993
- Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.Proceedings of the National Academy of Sciences, 1993
- Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.The Journal of Experimental Medicine, 1993
- Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein–Barr virus infectionThe Journal of Pathology, 1993
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991